文献速递腹部技术与安全MR

简化非增强MRI方案对肝细胞癌监测的诊断效能

Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

回顾性纳入226例肝硬化患者,评估由脂肪抑制T2WI和DWI组成的简化非增强MRI方案(Set1)及加做T1同反相位(Set2)对肝细胞癌的逐患者诊断效能,并与AFP联合分析;Set1敏感度84.4%/87.3%、特异度86.8%/86.8%,两套图像敏感度无显著差异(p=0.063),联合AFP后敏感度更高但无统计学意义。

要点

  • 脂肪抑制T2WI联合DWI的简化非增强MRI方案对肝硬化肝细胞癌监测敏感度达84.4%/87.3%。
  • 加做T1同反相位后敏感度略升至87.3%/89.6%,但与Set1无显著差异(p=0.063)。
  • 合并AFP后敏感度更高但无统计学意义;合并腹水及病灶小于2 cm与敏感度相关(p<0.05)。

核心结论

  • 由脂肪抑制T2WI和DWI组成的简化非增强MRI方案高度敏感,可能是肝硬化肝细胞癌监测的可行方法。
  • 加做T1同反相位及AFP可能提高该方案的敏感度。

研究设计与样本

  • 回顾性研究,纳入8年间因肝细胞癌监测接受MRI的226例患者。
  • Set1由扩散加权成像和呼吸触发脂肪抑制快速自旋回波T2加权成像组成;Set2为Set1加做T1同反相位图像。
  • 由两名阅片者依据预定标准独立将图像集判为肝细胞癌阳性或阴性,并与AFP联合评估诊断效能。

诊断标准与关键数值

  • Set1阅片者1/阅片者2的敏感度84.4%/87.3%、特异度86.8%/86.8%、准确率85.0%/87.2%。
  • Set2阅片者1/阅片者2的敏感度87.3%/89.6%、特异度81.1%/79.2%、准确率85.8%/87.2%。
  • 两套图像敏感度无显著差异(p=0.063)。
  • Set1联合AFP敏感度87.3%/89.6%(p=0.063/>0.99),Set2联合AFP敏感度89.6%/89.6%(p=0.125/>0.99),均较单独MRI高但无统计学意义。
  • 极早期肝细胞癌中Set1敏感度73.1%/76.9%,Set2敏感度76.9%/82.7%。

临床应用与阅片要点

  • 合并肝周腹水及病灶大小小于2 cm与诊断敏感度相关(p<0.05)。
  • 作者认为简化非增强MRI方案可能是肝硬化肝细胞癌监测的可行方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the per-patient diagnostic performance of a minimized non-contrast MRI protocol for hepatocellular carcinoma (HCC) surveillance in cirrhotic liver, as well as factors affecting diagnostic sensitivity.

METHODS: A total of 226 patients who underwent MRI for HCC surveillance over an 8 year period were included in this retrospective study. Set1 consisted of diffusion-weighted imaging and respiratory-triggered, fast-spin echo T2-weighted imaging with fat suppression. Set2 included T1-weighted in/opposed-phase images added to the images from Set1. Image sets were scored as positive or negative for HCC according to predetermined criteria by two readers independently. The diagnostic performance of the two sets in conjunction with α-fetoprotein (AFP) was assessed and compared using the McNemar test. Logistic regression was used to determine factors that affected sensitivity.

RESULTS: The sensitivity, specificity, and accuracy of Set1 of readers 1 and 2 were 84.4%/87.3%, 86.8%/86.8%, and 85.0%/87.2%, respectively; and those for Set2 were 87.3%/89.6%, 81.1%/79.2%, and 85.8/87.2%, respectively. The sensitivities of the sets were not significantly different (p = 0.063). Sensitivities of both sets in conjunction with AFP were higher than those of MRI alone without statistical significance (87.3%/89.6%, p = 0.063/> 0.99; 89.6%/89.6%, p = 0.125/> 0.99). In very early-stage HCC, the sensitivities of Sets1 and 2 were 73.1%/76.9% and 76.9%/82.7%, respectively. Perihepatic ascites and size less than 2 cm were associated with sensitivity (p < 0.05).

CONCLUSIONS: A minimized non-contrast MRI protocol consisting of Fat-sat T2WI and DWI is highly sensitive and may be a viable method for HCC surveillance of the cirrhotic liver. The inclusion of T1-weighted in/opposed-phase and AFP may increase this sensitivity.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Kim JS, Lee JK, Baek SY, et al. Diagnostic performance of a minimized protocol of non-contrast MRI for hepatocellular carcinoma surveillance. Abdom Radiol (NY). 2020. PMID: 31650374. doi:10.1007/s00261-019-02277-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。